C-type Lectin-like Receptors (CTLRs)

C-型凝集素样受体 (CTLRs) 是一类含有类似 C 型凝集素结构域,但不一定依赖钙离子识别配体的蛋白质受体。根据其细胞内信号传导基序可分为激活受体和抑制受体。CTLRs 能够识别病原体相关分子模式 (PAMPs) 和损伤相关分子模式 (DAMPs),在先天性免疫和适应性免疫中发挥重要作用。结合配体后,CTLRs 作为抗原摄取受体,将抗原内化呈递给 T 细胞,并激活 NF-κB、IFN 和炎性小体等多种信号通路,调节免疫细胞功能。CTLRs 表达或功能的异常与肿瘤、感染性疾病和自身免疫性疾病等密切相关[1][2]。

C-type Lectin-like Receptors (CTLRs) are a class of protein receptors that contain a C-type lectin-like domain but do not necessarily rely on calcium ions to recognize ligands. They are usually classified as activating or inhibitory receptors, based on their intracellular signaling motifs. CTLRs are capable of recognizing pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs), and play important roles in innate and adaptive immunity. After binding to ligands, CLRs act as antigen-uptake receptors, internalize antigens and present them to T cells, and activate multiple signaling pathways such as NF-κB, IFN, and inflammasomes to regulate the functions of immune cells. Abnormal expression or function of CLRs is closely related to cancer, infectious diseases, autoimmune diseases, and others[1][2].

共 31种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
7-Hydroxy-2,2-dimethyl-4-chromanone

7-Hydroxy-2,2-dimethyl-4-chromanone(化合物 41)是 DC-SIGN(树突状细胞特异性细胞间粘附分子 3-抓取非整合素)的抑制剂,IC50 为 4.66 mM,而 DC-SIGN 是存在于巨噬细胞和树突状细胞表面的 C 型凝集素(C-type lectin)受体。

17771-33-4
Inhibitor
97.0%
7-Hydroxy-2,2-dimethyl-4-chromanone
ABC-015

ABC-015 是一种靶向 KLRG1 的人类单克隆抗体 (mAb),可用于多发性骨髓瘤的研究。

Inhibitor
ABC-015
Anti-CD371/CLEC12A Antibody (H6e7)

Anti-CD371/CLEC12A Antibody (H6e7) 是一种靶向 CD371/CLEC12A 的人源单克隆抗体 (mAb),推荐的同型对照为 Human IgG1 kappa, Isotype Control (MS-E04981)。

Inhibitor
96.56%
Anti-CD371/CLEC12A Antibody (H6e7)
Anti-Dectin-1 Antibody (2M24)

Anti-Dectin-1 Antibody (2M24) 是一种靶向 Dectin-1 的人源化 IgG1 单克隆抗体,推荐的同型对照为 Human IgG1 kappa, Isotype Control (MS-E04981)。

Inhibitor
97.29%
Anti-Dectin-1 Antibody (2M24)
Anti-Human/Monkey NKG2D Antibody (16F16)

Anti-Human/Monkey NKG2D Antibody (16F16) 是一种靶向人/猴 NKG2D 的抗体,其同型对照可参考 Human IgG4 (S228P) kappa, Isotype Control (MS-E39019)。

Inhibitor
Anti-Human/Monkey NKG2D Antibody (16F16)
Anti-Human/Mouse NKG2D Antibody (ADI-27724)

Anti-Human/Mouse NKG2D Antibody (ADI-27724) 是一种靶向人/小鼠 NKG2D 的抗体,其同型对照可参考 Mouse IgG1 kappa, Isotype Control (MS-Y84731)。

Inhibitor
Anti-Human/Mouse NKG2D Antibody (ADI-27724)
Anti-Human/Mouse NKG2D Antibody (ADI-27740)

Anti-Human/Mouse NKG2D Antibody (ADI-27740) 是一种靶向人/小鼠 NKG2D 的抗体,其同型对照可参考 Mouse IgG1 kappa, Isotype Control (MS-Y84731)。

Inhibitor
Anti-Human/Mouse NKG2D Antibody (ADI-27740)
Anti-MICA/B Antibody (7C6)

Anti-MICA/B Antibody (7C6) 是一种靶向 MICA/B α3 结构域的人源化单克隆抗体,可增强外周、肝脏及肿瘤浸润 NK 细胞针对表达 MICA/B 的肿瘤细胞的脱颗粒作用和 IFNγ 产生,并通过结合 NK 细胞的 Fc 受体介导针对肿瘤细胞的抗体依赖性细胞毒性 (ADCC),可用于肝内胆管癌的研究。

Inhibitor
Anti-MICA/B Antibody (7C6)
Anti-Mouse CD209b Antibody (22D1)

Anti-Mouse CD209b Antibody (22D1) 是一种来源于亚美尼亚仓鼠宿主的抗小鼠 CD209b IgG1 抗体抑制剂,可阻断 SIGN-R1,并可用于感染、炎症和免疫学等方面的研究,如弓形虫感染和肺炎。

Inhibitor
99.00%
Anti-Mouse CD209b Antibody (22D1)
Anti-Mouse CD370 Antibody (1F6)

Anti-Mouse CD370 Antibody (1F6) 可与小鼠 CD370(也称为 CLEC9A 或 DNGR1)反应,而 CD370 是一种具有单个胞外 C 型凝集素结构域的 II 型膜蛋白,推荐的同型对照为 Rat IgG1 kappa, Isotype Control (MS-C94126)。

Inhibitor
97.95%
Anti-Mouse CD370 Antibody (1F6)
Anti-Mouse CLEC9A/CD370 Antibody (7H11)

Anti-Mouse CLEC9A/CD370 Antibody (7H11) 是一种源自大鼠的 IgG1 κ 型抗体抑制剂,靶向小鼠 CLEC9A/CD370,可与小鼠 CLEC9A(C 型凝集素结构域家族成员 9A)发生反应并阻断 CLEC9A,可用于癌症和免疫学研究,如 B16.F10-OVA 肿瘤。

Inhibitor
95%
Anti-Mouse CLEC9A/CD370 Antibody (7H11)
Anti-Mouse Ly49C Antibody (4LO3311)

Anti-Mouse Ly49C Antibody (4LO3311) 可与小鼠 Ly49C 反应,并识别位于茎区紧邻碳水化合物识别结构域的 32 个氨基酸片段中的表位,推荐的同型对照为 Mouse IgG3 kappa, Isotype Control (MS-N67582)。

Inhibitor
Anti-Mouse Ly49C Antibody (4LO3311)

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础